Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination

Accumulating evidence demonstrates the importance of CD4(+) T cells in antitumor immune responses. Identifying promiscuous MHC class II-binding peptides derived from relevant tumor-associated antigens that specifically target CD4(+) helper T cells in vivo represent a powerful approach to fully explo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dosset, Magalie, Vauchy, Charline, Beziaud, Laurent, Adotevi, Olivier, Godet, Yann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661170/
https://www.ncbi.nlm.nih.gov/pubmed/23802085
http://dx.doi.org/10.4161/onci.23430
_version_ 1782270640474030080
author Dosset, Magalie
Vauchy, Charline
Beziaud, Laurent
Adotevi, Olivier
Godet, Yann
author_facet Dosset, Magalie
Vauchy, Charline
Beziaud, Laurent
Adotevi, Olivier
Godet, Yann
author_sort Dosset, Magalie
collection PubMed
description Accumulating evidence demonstrates the importance of CD4(+) T cells in antitumor immune responses. Identifying promiscuous MHC class II-binding peptides derived from relevant tumor-associated antigens that specifically target CD4(+) helper T cells in vivo represent a powerful approach to fully exploit these cells for anticancer immunotherapy.
format Online
Article
Text
id pubmed-3661170
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-36611702013-06-25 Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination Dosset, Magalie Vauchy, Charline Beziaud, Laurent Adotevi, Olivier Godet, Yann Oncoimmunology Author's View Accumulating evidence demonstrates the importance of CD4(+) T cells in antitumor immune responses. Identifying promiscuous MHC class II-binding peptides derived from relevant tumor-associated antigens that specifically target CD4(+) helper T cells in vivo represent a powerful approach to fully exploit these cells for anticancer immunotherapy. Landes Bioscience 2013-03-01 2013-03-01 /pmc/articles/PMC3661170/ /pubmed/23802085 http://dx.doi.org/10.4161/onci.23430 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Dosset, Magalie
Vauchy, Charline
Beziaud, Laurent
Adotevi, Olivier
Godet, Yann
Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
title Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
title_full Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
title_fullStr Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
title_full_unstemmed Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
title_short Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
title_sort universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661170/
https://www.ncbi.nlm.nih.gov/pubmed/23802085
http://dx.doi.org/10.4161/onci.23430
work_keys_str_mv AT dossetmagalie universaltumorreactivehelperpeptidesfromtelomeraseasnewtoolsforanticancervaccination
AT vauchycharline universaltumorreactivehelperpeptidesfromtelomeraseasnewtoolsforanticancervaccination
AT beziaudlaurent universaltumorreactivehelperpeptidesfromtelomeraseasnewtoolsforanticancervaccination
AT adoteviolivier universaltumorreactivehelperpeptidesfromtelomeraseasnewtoolsforanticancervaccination
AT godetyann universaltumorreactivehelperpeptidesfromtelomeraseasnewtoolsforanticancervaccination

Ejemplares similares